Human cytomegalovirus IE86 protein binds to cellular Mcm3 protein but does not inhibit its binding to the Epstein-Barr virus oriP in U373MG-p220.2 cells

Acta Virologica

Volumn 54, Issue 2, 2010, Pages 125-130

  Song, Y J ^a   Stinski, M F ^b  

^a Gachon University   (South Korea)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Cell cycle; DNA replication; Human cytomegalovirus

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; IMMEDIATE EARLY PROTEIN; MINICHROMOSOME MAINTENANCE PROTEIN 3; PROTEIN IE86; PROTEIN ORIP; UNCLASSIFIED DRUG; VIRUS PROTEIN; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; EBV ENCODED NUCLEAR ANTIGEN 1; EBV-ENCODED NUCLEAR ANTIGEN 1; EPSTEIN BARR VIRUS ANTIGEN; IE2 PROTEIN, CYTOMEGALOVIRUS; MCM3 PROTEIN, HUMAN; NUCLEAR PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL CYCLE; CONTROLLED STUDY; DNA REPLICATION; DNA SYNTHESIS; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; PROTEIN BINDING; BINDING SITE; CELL LINE; CYTOMEGALOVIRUS; DNA REPLICATION ORIGIN; GENETICS; METABOLISM;

HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5;

BINDING SITES; CELL CYCLE PROTEINS; CELL LINE; CYTOMEGALOVIRUS; DNA REPLICATION; DNA-BINDING PROTEINS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; NUCLEAR PROTEINS; PROTEIN BINDING; REPLICATION ORIGIN; TRANS-ACTIVATORS;

EID: 77955885411     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: 10.4149/av_2010_02_125     Document Type: Article

References (30)

1. Adams A. (1987) Replication of latent Epstein-Barr virus genomes in Raji cells. J. Virol. 61, 1743-1746.
2. Bell SP, Dutta A. (2002) DNA replication in eukaryotic cells. Annu. Rev. Biochem. 71, 333-374. doi:10.1146/annurev. biochem.71.110601.135425
3. Biswas N, Sanchez V, Spector DH. (2003) Human cytomegalovirus infection leads to accumulation of geminin and inhibition of the licensing of cellular DNA replication. J. Virol. 77, 2369-2376.
4. Castillo JP, Kowalik TF. (2002) Human cytomegalovirus immediate early proteins and cell growth control. Gene 290, 19-34.
5. Chaudhuri B, Xu H, Todorov I, Dutta A, Yates JL. (2001) Human DNA replication initiation factors, ORC and MCM, associate with oriP of Epstein-Barr virus. Proc. Nat.l Acad. Sci. USA 98, 10085-10089.
6. Chen J, Stinski MF. (2000) Activation of transcription of the human cytomegalovirus early UL4 promoter by the Ets transcription factor binding element. J. Virol. 74, 9845-9857.
7. Fortunato EA, Sommer MH, Yoder K, Spector DH. (1997) Identification of domains within the human cytomegalovirus major immediate-early 86-kilodalton protein and the retinoblastoma protein required for physical and functional interaction with each other. J. Virol. 71, 8176-8185.
8. Gahn TA, Schildkraut CL. (1989) The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication. Cell 58, 527-535.
9. Gardella T, Medveczky P, Sairenji T, Mulder C. (1984) Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis. J. Virol. 50, 248-254.
10. Graham FL, van der Eb AJ. (1973) A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-467.
11. Hagemeier C, Caswell R, Hayhurst G, Sinclair J, Kouzarides T. (1994) Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein. EMBO J. 13, 2897-2903.
12. Harrison S, Fisenne K, Hearing J. (1994) Sequence requirements of the Epstein-Barr virus latent origin of DNA replication. J. Virol. 68, 1913-1925.
13. Hirai K, Shirakata M. (2001) Replication licensing of the EBV oriP minichromosome. Curr. Top. Microbiol. Immunol. 258, 13-33.
14. Kalejta RF, Shenk T. (2002) Manipulation of the cell cycle by human cytomegalovirus. Front. Biosci. 7, d295-306.
15. Korgaonkar C, Zhao L, Modestou M, Quelle DE. (2002) ARF function does not require p53 stabilization or Mdm2 relocalization. Mol. Cell. Biol. 22, 196-206.
16. Lei M, Tye BK. (2001) Initiating DNA synthesis from recruiting to activating the MCM complex. J. Cell. Sci. 114, 1447-1454.
17. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato JY. (1994) D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14, 2066-2076.
18. Mecsas J, Sugden B. (1987) Replication of plasmids derived from bovine papilloma virus type 1 and Epstein-Barr virus in cells in culture. Annu. Rev. Cell. Biol. 3, 87-108.
19. Middleton T, Sugden B. (1992) EBNA1 can link the enhancer element to the initiator element of the Epstein-Barr virus plasmid origin of DNA replication. J. Virol. 66, 489-495.
20. Murphy EA, Streblow DN, Nelson JA, Stinski MF. (2000) The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells. J. Virol. 74, 7108-7118.
21. Noris E, Zannetti C, Demurtas A, Sinclair J, De Andrea M, Gariglio M, Landolfo S. (2002) Cell cycle arrest by human cytomegalovirus 86-kDa IE2 protein resembles premature senescence. J. Virol. 76, 12135-1248.
22. Song YJ, Stinski MF. (2002) Effect of the human cytomegalovirus IE86 protein on expression of E2F-responsive genes a DNA microarray analysis. Proc. Natl. Acad. Sci. USA 99, 2836-2841.
23. Song YJ, Stinski MF. (2005) Inhibition of cell division by the human cytomegalovirus IE86 protein role of the p53 pathway or cyclin-dependent kinase 1/cyclin B1. J. Virol. 79, 2597-2603.
24. Stinski MF. (1977) Synthesis of proteins and glycoproteins in cells infected with human cytomegalovirus. J. Virol. 23, 751-767.
25. Stinski MF, Song Y-J. (2002) CMV involvement in cell regulation. In Bogner E, Holzenburg A (Eds) Structure-Function Relationships of Human Pathogenic Viruses. Kluwer Academic/Plenum Publishers, New York and London, pp. 485-507.
26. Wiebusch L, Hagemeier C. (2001) The human cytomegalovirus immediate early 2 protein dissociates cellular DNA synthesis from cyclin-dependent kinase activation. EMBO J. 20, 1086-1098.
27. Wiebusch L, Uecker R, Hagemeier C. (2003) Human cytomegalovirus prevents replication licensing by inhibiting MCM loading onto chromatin. EMBO Rep. 4, 42-46.
28. Yates J, Warren N, Reisman D, Sugden B. (1984) A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. USA 81, 3806-3810.
29. Yates JL, Camiolo SM, Bashaw JM. (2000) The minimal replicator of Epstein-Barr virus oriP. J. Virol. 74, 4512-4522.
30. Yates JL, Warren N, Sugden B. (1985) Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313, 812-815.